ponasterone a has been researched along with alpha-synuclein in 2 studies
| Studies (ponasterone a) | Trials (ponasterone a) | Recent Studies (post-2010) (ponasterone a) | Studies (alpha-synuclein) | Trials (alpha-synuclein) | Recent Studies (post-2010) (alpha-synuclein) |
|---|---|---|---|---|---|
| 162 | 0 | 24 | 10,821 | 29 | 8,011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cooper, JM; Orth, M; Schapira, AH; Taanman, JW; Tabrizi, SJ; Warner, TT; Wilkinson, JM | 1 |
| Cooper, JM; Korlipara, LV; Messmer, K; Orth, M; Schapira, AH; Tabrizi, SJ; Tomlinson, C | 1 |
2 other study(ies) available for ponasterone a and alpha-synuclein
| Article | Year |
|---|---|
Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity.
Topics: alpha-Synuclein; Blotting, Western; Cell Death; Cell Line; Cell Size; Dopamine; Drug-Related Side Effects and Adverse Reactions; Ecdysterone; Gene Expression; Genetic Predisposition to Disease; Humans; Immunohistochemistry; Male; Mutation; Nerve Tissue Proteins; Neurons; Parkinson Disease; Parkinson Disease, Secondary; Synucleins; Transfection | 2000 |
G209A mutant alpha synuclein expression specifically enhances dopamine induced oxidative damage.
Topics: Aconitate Hydratase; Adrenergic Uptake Inhibitors; alpha-Synuclein; Blotting, Western; Cell Line; Cells, Cultured; Dopamine; Ecdysterone; Glutathione; Herbicides; Humans; Immunohistochemistry; Mutation; Nerve Tissue Proteins; Oxidative Stress; Paraquat; Reserpine; Synucleins | 2004 |